NCT01896505View on ClinicalTrials.gov

A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 30, 2013

Primary Completion Date

October 21, 2016

Study Completion Date

October 21, 2016

Conditions
Sarcoma
Interventions
DRUG

KCP-330

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Centre, New York

M5T 2M9

Princess Margaret Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY